Magellan Biosci Navigates TREK Diagnostics Sale to Strategic
Magellan Biosciences, the Boston-based diagnostics company, sold its TREK Diagnostic Systems, the company’s microbiology business, to strategic acquirer Thermo Fisher Scientific. Terms of the deal were not publicized. Backers of Magellan include Abingworth Management, Hambrecht & Quist Capital Management, KBL Healthcare Ventures, Ampersand Ventures, New England Partners Capital LP, Nexus Medical Partners II SICAR, and Boston Community Venture Fund.
19 July 2011•2 mins read
